Correction to: British Journal of Cancer (2016) 94, 1765-1769; https://doi.org/10.1038/sj.bjc.6603170; published online 23 May 2006.
Author information
Authors and Affiliations
Corresponding author
Additional information
Several of the authors are employed by a company (Novartis) whose product is described in the present work.
Rights and permissions
About this article
Cite this article
Weisberg, E., Manley, P., Mestan, J. et al. Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. Br J Cancer 121, 282 (2019). https://doi.org/10.1038/s41416-019-0505-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-019-0505-7